JS1-1-01

N/A

Report date: 2026/05/14 20:00:28
NME

Base Information

Drug NameJS1-1-01
Drug Alias NameJS1-1-01
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin reuptake inhibitorsNorepinephrine reuptake inhibitorsDopamine reuptake inhibitors +[4] 
TargetsSerotonin transporterNorepinephrine transporterDopamine transporter +[4] 
Therapy Area/IndicationsDepressive Disorder, MajorDepressive DisorderDepression
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesTianjin Tasly Pharmaceutical Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesTianjin Tasly Sants Pharmaceutical Co LtdJiangsu Tasly Diyi Pharmaceutical Co LtdTianjin Tasly Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsDepressive Disorder, MajorDepressive DisorderDepression
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A